Opportunity ID: 317499

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AG-20-028
Funding Opportunity Title: Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.866 — Aging Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 25, 2019
Last Updated Date: Jun 25, 2019
Original Closing Date for Applications: Oct 22, 2019
Current Closing Date for Applications: Oct 22, 2019
Archive Date: Nov 27, 2019
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: City or township governments
For profit organizations other than small businesses
Special district governments
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Independent school districts
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
State governments
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites applications proposing to conduct research involving pragmatic clinical trials on dissemination and implementation of practical approaches to hypertension treatment and control strategies among older adults with multimorbidity in order to prevent sequelae, including mild cognitive impairment and dementia.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-028.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00252347 Sep 22, 2019 Oct 22, 2019 View

Package 1

Mandatory forms

317499 RR_SF424_2_0-2.0.pdf

317499 PHS398_CoverPageSupplement_4_0-4.0.pdf

317499 RR_OtherProjectInfo_1_4-1.4.pdf

317499 PerformanceSite_2_0-2.0.pdf

317499 RR_KeyPersonExpanded_2_0-2.0.pdf

317499 RR_Budget_1_4-1.4.pdf

317499 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

317499 RR_SubawardBudget30_1_4-1.4.pdf

317499 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T19:14:38-05:00

Share This Post, Choose Your Platform!

About the Author: